US Patent 8883449 Single-chain insulin

Patent 8883449 was granted and assigned to Novo Nordisk on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8883449

Patent Inventor Names

Peter Madsen0

Anders Robert Sørensen0

Morten Schlein0

Thomas Børglum Kjeldsen0

Date of Patent

November 11, 2014

Patent Application Number

12251901

Date Filed

October 15, 2008

Patent Citations Received

‌

US Patent 12059452 Fusion proteins

‌

US Patent 12077568 Engineered active single-polypeptide chain insulin analogs

Patent Primary Examiner

‌

Christine J. Saoud

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8883449 Single-chain insulin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API